Should We be Combining Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Treating Diabetes? (Q50138267)
Jump to navigation
Jump to search
scientific article published on 5 January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should We be Combining Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Treating Diabetes? |
scientific article published on 5 January 2018 |
Statements
1 reference
Should We be Combining Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Treating Diabetes? (English)
1 reference
Milton Packer
1 reference
5 January 2018
1 reference
Identifiers
1 reference
1 reference